Cervel Neurotech, Inc. (formerly NeoStim, Inc.) located in San Mateo, CA is a privately held medical device company that is pioneering an innovative, proprietary approach to non-invasive deep brain neuro-modulation. Cervel’s technology is a form of repetitive transcranial magnetic stimulation (rTMS) which uses magnetic fields to induce electrical currents within the brain to modulate the function of specific areas. The company was founded in 2008 by M. Bret Schneider, MD, and David J. Mishelevich, MD, PhD, and entrepreneur Michael J. Partsch, using technology licensed from Stanford Univesity.
Acquired by Rio Grande Neurosciences in 2015